Biomarkers in COPD: Time for a deep breath

Thorax

Volumn 62, Issue 8, 2007, Pages 657-660

  Stockley, R A ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DRUG INDUSTRY; EDITORIAL; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SCREENING;

BIOLOGICAL MARKERS; FORCED EXPIRATORY VOLUME; HUMANS; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION; SENSITIVITY AND SPECIFICITY;

EID: 34547781171     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2007.084228     Document Type: Editorial

References (22)

1. Sevenoaks MJ, Stockley RA. Chronic obstructive pulmonary disease, inflammation and co-morbidity - a common inflammatory type? Respir Res 2006;70:1-9.
2. Li Y-P, Schwartz RJ, Waddell ID, et al. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α. FASEB J 1998;12:871-80.
3. Agusti AG, Sauleda J, Miralles C, et al. Skeletal muscle apoptosis and weightloss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:485-9.
4. Syn DD, Mann SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005;2:8-11.
5. Rhana JS, Mitelman MA, Sheikh J, et al. Chronic obstructive pulmonary disease, asthma and risk of type II diabetes in women. Diabetes Care 2004;27:2478-84.
6. Bolton CE, Ionescu AA, Shiels KM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:1286-93.
7. Stockley RA. Neutrophils and protease/antiprotease imbalance. Am J Respir Crit Care Med 1999;160:S49-52.
8. Chung A, Wang RD, Tai H, et al. Tumor necrosis factor alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2004;170:492-8.
9. Stewart CE, Newcomb PV, Holly JM. Multifaceted roles of TNF-alpha in myoblast destruction: a multitude of signal transduction pathways. J Cell Physiol 2004;198:237-47.
10. Hotamisligil GS, Peraldi P, Budavari A, et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science 1996;271:665-8.
11. Gianni W, Ricci A, Gazzaniga P, et al. Raloxifene modulates interleukin-6 and rumor necrosis facror-α synthesis in vivo: results from a pilot clinical study. J Clin Endocrinol Metab 2004;89:6097-9.
12. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
13. Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004;351:2599-610.
14. Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 2005;4:977-87.
15. de Torres JP, Cordoba-Lanus E, Lopez-Aguilar C, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006;27:902-7.
16. Dahl M, Vestbo J, Lange P, et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:250-5.
17. Donaldson GC, Seemungal TA, Patel IS, et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005;128:1995-2004.
18. Donaldson CG. C-reactive protein: does it predict mortality? Am J Respir Crit Care Med 2007;175:209-10.
19. Franciosi LG, Page CP, Celli BR. Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2006;19:189-99.
20. Parr DG, White AJ, Bayley DL, et al. Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study. Resp Res 2006;136:1-11.
21. Man P, Connell J, Anthonisen N, et al. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006;61:849-53.
22. Fogarty A, Jones S, Brirton JR, et al. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 2007;62:515-20.